Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
+2,613
New +$217K 0.03% 407
2025
Q4
– Sell
-4,374
Closed -$294K – 434
2025
Q3
$294K Sell
4,374
-1,343
-23% -$106K 0.04% 336
2025
Q2
$499K Sell
5,717
-377
-6% -$29.6K 0.08% 195
2025
Q1
$416K Buy
6,094
+954
+19% +$77.8K 0.03% 222
2024
Q4
$400K Buy
+5,140
New +$381K 0.02% 247
2024
Q3
– Sell
-4,663
Closed -$529K – 434
2024
Q2
$529K Sell
4,663
-187
-4% -$23.6K 0.03% 199
2024
Q1
$673K Buy
4,850
+245
+5% +$30.8K 0.04% 153
2023
Q4
$571K Buy
4,605
+154
+3% +$15.7K 0.04% 159
2023
Q3
$415K Buy
4,451
+32
+0.7% +$3.61K 0.03% 191
2023
Q2
$568K Buy
4,419
+753
+21% +$91.1K 0.04% 132
2023
Q1
$426K Buy
3,666
+168
+5% +$18.8K 0.03% 169
2022
Q4
$396K Sell
3,498
-181
-5% -$19.9K 0.03% 171
2022
Q3
$296K Sell
3,679
-206
-5% -$17.4K 0.03% 184
2022
Q2
$290K Sell
3,885
-339
-8% -$30.9K 0.03% 197
2022
Q1
$540K Buy
4,224
+2,400
+132% +$263K 0.05% 105
2021
Q4
$245K Buy
1,824
+1,768
+3,157% +$254K 0.02% 257
2021
Q3
$8K Sell
56
-48
-46% -$6.05K ﹤0.01% 861
2021
Q2
$11K Sell
104
-316
-75% -$30.3K ﹤0.01% 739
2021
Q1
$38K Hold
420
– – ﹤0.01% 534
2020
Q4
$39K Sell
420
-84
-17% -$7.5K 0.01% 514
2020
Q3
$52K Buy
504
+8
+2% +$836 0.01% 363
2020
Q2
$50K Buy
496
+4
+0.8% +$358 0.01% 356
2020
Q1
$33K Hold
492
– – 0.01% 318
2019
Q4
$27K Buy
492
+464
+1,657% +$22K 0.01% 356
2019
Q3
$1K Buy
28
+8
+40% +$311 ﹤0.01% 385
2019
Q2
$1K Sell
20
-16
-44% -$503 ﹤0.01% 364
2019
Q1
$1K Hold
36
– – ﹤0.01% 312
2018
Q4
$1K Buy
+36
New +$1.14K ﹤0.01% 479

Other funds holding DXCM

Ellevest's DXCM Position: Q3 2026 in Review

Ellevest opened a new position in DexCom (DXCM) in Q3 2026: 2,613 shares worth $226K. The stake represents 0.03% of the portfolio and ranks #407 among its holdings. This is a return to the name: Ellevest previously reported a position in DXCM as recently as Q3 2025.

Ellevest first reported a position in DXCM in Q4 2018 and has held it in 28 quarters since. The position peaked at $673K in Q1 2024. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Ellevest held 2,613 shares of DexCom worth $226K as of Q3 2026.
  • DexCom was a new Ellevest position in Q3 2026.
  • DexCom made up 0.03% of Ellevest's portfolio in Q3 2026, its #407 holding.
  • Ellevest first reported a position in DexCom in Q4 2018 and has held it in 28 quarters since.
  • Ellevest's DexCom position peaked at $673K in Q1 2024.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.